Belimumab Efficacy is ‘Mild’ but Market Potential Still Great†
4
Chat with Paper
AI Agents for this Paper
No abstract available for this paper.
Keywords
BelimumabSystemic lupus erythematosusMedicineClinical trialSykDiseasePharmacologyInternal medicine
Chat
Click to start Chat